The Story
Understanding the Guardant Reveal™ Cancer Test
Guardant Reveal MRD, a simple blood test for patients with early-stage Colorectal (CRC), Breast and Lung Cancers to help with recurrence monitoring and check if there is cancer remaining in your body after surgery or once in remission.
**Do not book unless you have had an Oncologist consultation**
Suitable for individuals with early-stage cancer diagnosis history and are in remission, or have undergone surgery for CRC, Breast and Lung cancers only.
To take the test:
1.Book a 30-minute mandatory Oncologist Consultation to determine your suitability for the test (fee of £149, refundable if referred for the test).
2. The Oncologist will determine which cancer test is most suitable for your condition. Tests can taken at home with a nurse visit or in a clinic near you.
Want to find out more? Enquire via the form and a member of the team will get back to you.
Details & Craftsmanship
Every detail has been carefully considered to bring you the perfect product.
Details & Craftsmanship
Every detail has been carefully considered to bring you the perfect product.
Description
Understanding the Guardant Reveal™ Cancer Test
Guardant Reveal MRD, a simple blood test for patients with early-stage Colorectal (CRC), Breast and Lung Cancers to help with recurrence monitoring and check if there is cancer remaining in your body after surgery or once in remission.
**Do not book unless you have had an Oncologist consultation**
Suitable for individuals with early-stage cancer diagnosis history and are in remission, or have undergone surgery for CRC, Breast and Lung cancers only.
To take the test:
1.Book a 30-minute mandatory Oncologist Consultation to determine your suitability for the test (fee of £149, refundable if referred for the test).
2. The Oncologist will determine which cancer test is most suitable for your condition. Tests can taken at home with a nurse visit or in a clinic near you.
Want to find out more? Enquire via the form and a member of the team will get back to you.
